Article Details

Neoantigen Based Personalized Cancer Therapeutic Vaccines Pipeline 2024: Detailed ...

Retrieved on: 2025-02-08 03:44:09

Tags for this article:

Click the tags to see associated articles and topics

Neoantigen Based Personalized Cancer Therapeutic Vaccines Pipeline 2024: Detailed .... View article details on hiswai:

Excerpt

EVX-01: Evaxion Biotech. NOUS-PEV: Nouscom. IMLYGIC (talimogene laherparepvec): Amgen. PROVENGE (sipuleucel-T): Dendreon Pharmaceuticals.

Article found on: www.barchart.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up